New progress, new hope in targeting the pain of chemotherapy; Chemotherapy Induced Peripheral Neuropathy has been one of the most difficult types of pain to target/treat.
read more
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange: EPCT) today announced that the targeted enrollment in a Phase IIb trial for EpiCept™ NP-1 in chemotherapy-induced peripheral neuropathy (CPN) has been attained. The tria... Read Post
Antidepressant Cymbalta (duloxetine) has been found to relieve the symptoms of chemotherapy-induced peripheral neuropathy, a painful tingling sensation many patients experience after undergoing chemotherapy. The researchers, from th... Read Post
Although oncologists have made great strides in many aspects of cancer treatment, one area that has remained very difficult to treat is peripheral neuropathy, namely pain that can be caused by the cancer or by its treatment. In thes... Read Post